A meta-analysis estimated that patients with Parkinson’s disease had lower vitamin D levels than healthy controls, and it seems that this is reflected in the loss of dopaminergic neurons; however, whether this associates the downregulation of LRRK2 with a significant impact on PD pathogenesis remains to be evaluated [51]. This evidence concerns the gene LRRK2 and Parkinson disease.